Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses by Jing Wang (6206297)

“…In contrast, reversing managed to natural ecosystems significantly increased NNM by 20% (9.7, 25.4%) and decreased NN by 89% (−125, −46%), indicating increasing N availability while decreasing potential N loss. …”

Degeneration Saline group presented with significant decreased final weight in relation to other groups. by Flavia Gomes Velasque Gama (21175112)

Smoking Behaviors of the participants categorized by the respective year. by Jae Yeon Jeong (11979030)

Subjects:

Drinking Behaviors of the male participants categorized by the respective year. by Jae Yeon Jeong (11979030)

Subjects:

Drinking Behaviors of the participants categorized by the respective year. by Jae Yeon Jeong (11979030)

Subjects:

Sleep and Mental health of the participants categorized by the respective year. by Jae Yeon Jeong (11979030)

Subjects:

General characteristics of the participants categorized by the respective year. by Jae Yeon Jeong (11979030)

Subjects:

Difference in drinking, smoking, and suicidal ideation by year. by Jae Yeon Jeong (11979030)

Subjects:

Drinking Behaviors of the female participants categorized by the respective year. by Jae Yeon Jeong (11979030)

Subjects:

Impact on different areas of health. by Margherita Molaro (17803989)

Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

Analytical framework and statistical methods. by Na Chen (153323)

Subjects:

Theoretical frameworks of social protection. by Na Chen (153323)

Subjects:

Prognostic Impact of Red Blood Cell-Platelet Ratio Trajectory Categories after PSM. by Jie Zhao (49409)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

Subjects:

S1 Data - by Kazuyoshi Ohkawa (836847)

Subjects: